What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to inform the public that UnitedHealth Group's senior management will be meeting with investors and analysts in the near future. It also serves to reaffirm the company's previously disclosed financial expectations for 2005.

Will new financial results or guidance be announced during these upcoming meetings?

This 8-K filing does not announce new financial results or specific guidance. However, it states that management will reaffirm the Company's publicly disclosed 2005 financial expectations, suggesting that the previously provided guidance remains in effect.

What are the risks associated with the forward-looking statements mentioned?

The filing includes a cautionary statement that actual results could differ materially from management's expectations due to various risks and uncertainties. These risks are typical in the healthcare industry and can be found in detail in UNH's other SEC filings, such as their annual (10-K) and quarterly (10-Q) reports.

Who will be representing UnitedHealth Group in these investor meetings?

William W. McGuire, M.D. (Chairman and Chief Executive Officer), Stephen J. Hemsley (President and Chief Operating Officer), and other senior members of the Company's management team will be participating in these meetings.

UNH 8-K: Regulation FD — Jun 13, 2005

Summary

UnitedHealth Group Incorporated (UNH) filed an 8-K on June 13, 2005, to disclose upcoming investor and analyst meetings scheduled for the latter half of June and early July 2005. During these sessions, senior management, including the CEO and President, will discuss the company's strategy, tactics, and future outlook. A key takeaway for investors is the reaffirmation of UnitedHealth Group's publicly disclosed 2005 financial expectations. While the filing does not provide specific financial figures, it signals management's confidence in meeting previously stated guidance. The report also includes a standard cautionary statement regarding forward-looking statements, reminding investors that actual results could differ materially due to various risks and uncertainties inherent in the healthcare industry.

Key Highlights

1Upcoming investor and analyst meetings scheduled for late June and early July 2005.
2Senior management, including CEO and President, will participate in these meetings.
3Discussions will cover company strategy, tactics, and future outlook.
4Reaffirmation of the Company's publicly disclosed 2005 financial expectations.
5Standard cautionary statement regarding forward-looking statements is included.
6No new material financial information is disclosed in this specific filing, but guidance is confirmed.

UNITEDHEALTH GROUP INC 8-K Report, Regulation FD Disclosure (Jun 13, 2005)

Summary

Key Highlights

Frequently Asked Questions